M.C. Conroy

751 total citations
28 papers, 594 citations indexed

About

M.C. Conroy is a scholar working on Immunology, Pharmacology and Physiology. According to data from OpenAlex, M.C. Conroy has authored 28 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Pharmacology and 9 papers in Physiology. Recurrent topics in M.C. Conroy's work include Mast cells and histamine (11 papers), Asthma and respiratory diseases (8 papers) and Drug-Induced Adverse Reactions (7 papers). M.C. Conroy is often cited by papers focused on Mast cells and histamine (11 papers), Asthma and respiratory diseases (8 papers) and Drug-Induced Adverse Reactions (7 papers). M.C. Conroy collaborates with scholars based in United States, Switzerland and Australia. M.C. Conroy's co-authors include Floyd J. Malveaux, N. Franklin Adkinson, Lawrence M. Lichtenstein, David O. Thueson, John A. Kennedy, David T. Connor, Robert J. Weikert, Paul C. Unangst, Catherine J. Fliszar and J. Michael Shipley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

M.C. Conroy

27 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Conroy United States 10 225 179 169 142 99 28 594
Nisebita Sahu United States 12 415 1.8× 144 0.8× 47 0.3× 12 0.1× 179 1.8× 15 685
Patty Trobridge United States 11 134 0.6× 65 0.4× 58 0.3× 30 0.2× 262 2.6× 12 571
M. Mathieu France 12 50 0.2× 61 0.3× 30 0.2× 28 0.2× 207 2.1× 17 398
Tomio Yamazaki Japan 17 75 0.3× 34 0.2× 31 0.2× 113 0.8× 163 1.6× 44 761
Juha Pekka Turunen Finland 14 238 1.1× 14 0.1× 268 1.6× 93 0.7× 300 3.0× 20 573
Georges Grard France 7 250 1.1× 38 0.2× 31 0.2× 32 0.2× 355 3.6× 9 550
Katherine A. Rouleau United States 13 152 0.7× 19 0.1× 30 0.2× 126 0.9× 221 2.2× 17 548
DL Urdal United States 13 412 1.8× 56 0.3× 30 0.2× 38 0.3× 304 3.1× 18 822
Tomoko Iguchi Japan 10 288 1.3× 102 0.6× 22 0.1× 25 0.2× 284 2.9× 14 655
Ari J. Salinger United States 12 201 0.9× 22 0.1× 75 0.4× 22 0.2× 186 1.9× 15 434

Countries citing papers authored by M.C. Conroy

Since Specialization
Citations

This map shows the geographic impact of M.C. Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Conroy more than expected).

Fields of papers citing papers by M.C. Conroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Conroy. The network helps show where M.C. Conroy may publish in the future.

Co-authorship network of co-authors of M.C. Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Conroy. A scholar is included among the top collaborators of M.C. Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Conroy. M.C. Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schimmer, Ralph C., Denis J. Schrier, Craig M. Flory, et al.. (1997). Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. The Journal of Immunology. 159(8). 4103–4108. 41 indexed citations
2.
Baragi, Vijay, David Brott, Luping Qiu, M.C. Conroy, & Narendra D. Lalwani. (1995). Immunofluorescence quantitation of stromelysin in human synovial fibroblasts by confocal laser scanning microscopy.. PubMed. 72(4). 484–90. 3 indexed citations
3.
4.
Baragi, Vijay, David Brott, Luping Qiu, M.C. Conroy, & Narendra D. Lalwani. (1994). Confocal Laser Scanning Immunofluorescence Imaging for Quantitation of Stromelysin in Human Synovial Fibroblasts. Annals of the New York Academy of Sciences. 732(1). 348–350. 1 indexed citations
5.
6.
Gilbertsen, Richard B., et al.. (1993). Activities of Two 9‐Deazaguanine Analogue Inhibitors of Purine Nucleoside Phosphorylase, CI‐972 and PD 141955, in Vitro and in Vivo. Annals of the New York Academy of Sciences. 685(1). 248–251. 6 indexed citations
7.
Wright, Clifford D., et al.. (1992). Differential regulation of human eosinophil, macrophage, and neutrophil functions by the allergic mediator release inhibitor CI-959. Inflammation Research. 36(1-2). 11–16. 1 indexed citations
8.
Mullican, Michael D., Roderick J. Sorenson, D. T. CONNOR, et al.. (1991). Novel thiophene-, pyrrole-, furan-, and benzene carboxamidotetrazoles as potential antiallergy agents. Journal of Medicinal Chemistry. 34(7). 2186–2194. 23 indexed citations
9.
Conroy, M.C., et al.. (1991). Inhibition of interleukin-2 production and lymphocyte responsiveness by the cell activation inhibitor, CI-959. Inflammation Research. 34(1-2). 53–55. 9 indexed citations
10.
11.
Wright, Clifford D., Paul J. Kuipers, M Hoffman, David O. Thueson, & M.C. Conroy. (1990). Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949: Mechanism of inhibitory activity. Biochemical and Biophysical Research Communications. 167(2). 828–834. 8 indexed citations
12.
Thueson, David O., et al.. (1990). CI-949: A new, potential antiallergy compound inhibits antigen-induced allergic reactions in guinea-pigs in vitro and in vivo. Pulmonary Pharmacology. 3(4). 203–208. 1 indexed citations
13.
Wright, Clifford D., et al.. (1990). Differential regulation of the activation of human eosinophils, macrophages, and neutrophils: Effect of the allergic mediator release inhibitor CI-949. Inflammation Research. 31(1-2). 11–15. 6 indexed citations
14.
15.
Schellenberg, R. Robert, et al.. (1990). CI-959, a New, Potential Antiallergic Drug, Inhibits Mediator Release from Lung and Contractions of Human Airways in vitro. International Archives of Allergy and Immunology. 93(2-3). 267–271. 4 indexed citations
16.
Unangst, Paul C., David T. Connor, Robert J. Weikert, et al.. (1989). Novel indolecarboxamidotetrazoles as potential antiallergy agents. Journal of Medicinal Chemistry. 32(6). 1360–1366. 108 indexed citations
17.
Gilbertsen, Richard B., et al.. (1989). In vitro effects of the antiallergy compound, CI-949, on interleukin-1 and 2 release, and on mitogen and alloantigen responsiveness. Inflammation Research. 27(3-4). 303–305. 2 indexed citations
18.
Thueson, David O., et al.. (1988). 146 Comparison of the effects of the allergic mediator release inhibitor CI-949 on the respiratory burst of human eosinophils, macrophages, and neutrophils. Journal of Allergy and Clinical Immunology. 81(1). 205–205. 1 indexed citations
19.
Conroy, M.C., et al.. (1982). Evaluation of 3H‐Histamine Incorporation into Human Peripheral Blood Leukocytes. Allergy. 37(5). 365–371. 1 indexed citations
20.
Malveaux, Floyd J., M.C. Conroy, N. Franklin Adkinson, & Lawrence M. Lichtenstein. (1978). IgE receptors on human basophils. Relationship to serum IgE concentration.. Journal of Clinical Investigation. 62(1). 176–181. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nisebita Sahu Breakdown of academic impact, for papers by Patty Trobridge Breakdown of academic impact, for papers by M. Mathieu Breakdown of academic impact, for papers by Tomio Yamazaki Breakdown of academic impact, for papers by Juha Pekka Turunen Breakdown of academic impact, for papers by Georges Grard Breakdown of academic impact, for papers by Katherine A. Rouleau Breakdown of academic impact, for papers by DL Urdal Breakdown of academic impact, for papers by Tomoko Iguchi Breakdown of academic impact, for papers by Ari J. Salinger
Rankless by CCL
2026